Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Vossloh AG

Start price
Target price
Perf. (%)
€42.25
16.12.20
€49.00
16.12.21
3.67%
17.12.21

Could be very worthwhile Investment >20% year
djuddi888 
16.12.20 50%
buy
CBAK Energy Technology Inc

Start price
Target price
Perf. (%)
€4.22
16.12.20
€4.00
1.42%
16.12.20

Revenue growth >5% per year expected
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Traumtanz 
16.12.20 50%
sell
Veru Inc

Start price
Target price
Perf. (%)
€9.15
15.12.20
€6.00
15.12.21
-18.03%
29.01.21

Capable Management
Good culture
Probably not worthwhile Investment
Few uniques
me8 
15.12.20 50%
buy
Avinger Inc.

Start price
Target price
Perf. (%)
€4.88
14.12.20
€20.00
301.64%
11.01.21

Could be worthwhile Investment >10% per year
DomRuinart 
14.12.20 50%
buy
ElringKlinger AG

Start price
Target price
Perf. (%)
€14.22
14.12.20
€15.00
2.11%
15.12.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stable Large shareholder and/or long term investor
Traumtanz 
14.12.20 50%
buy
Nuwellis Inc.

Start price
Target price
Perf. (%)
€6.00
14.12.20
€8.00
14.12.21
6.67%
11.01.21

Could be very worthwhile Investment >20% year
DomRuinart 
14.12.20 50%
sell
CBAK Energy Technology Inc

Start price
Target price
Perf. (%)
€4.06
14.12.20
€4.00
3.94%
16.12.20

Revenue growth >5% per year expected
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Traumtanz 
14.12.20 50%
buy
Anpac Bio-Medical Science Co.

Start price
Target price
Perf. (%)
€106.00
14.12.20
€240.00
14.12.21
-15.09%
29.01.21

Could be worthwhile Investment >10% per year
Good culture
Growths slower than the competition
Dependend from some customers or products
me8 
14.12.20 50%
buy
Zumtobel AG

Start price
Target price
Perf. (%)
€6.10
14.12.20
€7.00
6.39%
17.03.21

Known brand
Could be worthwhile Investment >10% per year
Capable Management
Future proof or reliable business model
gerihouse 
14.12.20 50%
sell
Evolus Inc

Start price
Target price
Perf. (%)
€3.13
14.12.20
-
-10.64%
28.12.20

Risky Investment
blaugold 
14.12.20 50%
buy
Catalyst Pharmaceutical Partners Inc

Start price
Target price
Perf. (%)
€3.06
13.12.20
-
13.12.21
1.50%
11.03.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Savour 
13.12.20 50%
buy
Alico Inc

Start price
Target price
Perf. (%)
€25.80
13.12.20
-
13.12.21
13.95%
14.12.21

Risky Investment
Maxfloh 
13.12.20 50%
buy
Nanostr.technol.

Start price
Target price
Perf. (%)
€57.50
13.12.20
-
13.12.21
-41.91%
14.12.21

Risky Investment
Maxfloh 
13.12.20 50%
buy
Ebix Inc.

Start price
Target price
Perf. (%)
€30.20
13.12.20
€35.00
13.12.21
-12.98%
14.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
skatcup 
13.12.20 60%
sell
SLM Solutions Group AG

Start price
Target price
Perf. (%)
€15.50
13.12.20
-
13.12.21
5.42%
14.12.21

overvalued
Revenue decline/stagnation expected
EBIT decline/stagnation expected
kostojunior 
13.12.20 50%
sell
Voltabox

Start price
Target price
Perf. (%)
€3.80
13.12.20
-
13.12.21
-55.21%
14.12.21

Probably not worthwhile Investment
Bad rating
High risks for its business
Growths much slower than the competition
kostojunior 
13.12.20 0%
sell
Curis Inc.

Start price
Target price
Perf. (%)
€6.35
13.12.20
-
13.12.21
37.01%
16.02.21

Below average Marketposition
Probably not worthwhile Investment
Significant cyclical dependencies
Little known brand
tinelchen 
13.12.20 50%
sell
Lexicon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.66
13.12.20
-
13.12.21
143.95%
16.02.21

Probably not worthwhile Investment
Significant cyclical dependencies
tinelchen 
13.12.20 50%
sell
Verrica Pharmaceuticals

Start price
Target price
Perf. (%)
€8.75
12.12.20
-
12.12.21
-2.29%
13.12.21

Probably not worthwhile Investment
PlusUltra 
12.12.20 50%
sell
Inseego Corp.

Start price
Target price
Perf. (%)
€12.26
12.12.20
-
12.12.21
-54.63%
13.12.21

Probably not worthwhile Investment
PlusUltra 
12.12.20 50%
sell
PhaseBio Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€3.60
12.12.20
-
12.12.21
-42.22%
13.12.21

Probably not worthwhile Investment
PlusUltra 
12.12.20 50%
buy
Harmony Gold Mining

Start price
Target price
Perf. (%)
€3.42
12.12.20
€8.50
12.12.21
2.92%
22.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Very low/no dividend yield expected
synergy1 
12.12.20 50%
buy
Formycon AG

Start price
Target price
Perf. (%)
€65.20
12.12.20
-
12.12.21
-7.06%
11.03.21

Could be worthwhile Investment >10% per year
Savour 
12.12.20 50%
sell
Overstock.com

Start price
Target price
Perf. (%)
€45.56
12.12.20
-
12.12.21
74.51%
08.02.21

Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
FXX 
12.12.20 50%
buy
Bluestone Resources Inc.

Start price
Target price
Perf. (%)
€1.27
11.12.20
€2.00
11.12.21
4.25%
12.12.21

Could be very worthwhile Investment >20% year
Lions_Investments 
11.12.20 50%